Advertisement

Topics

World Hepatitis Alliance Company Profile

01:13 EDT 21st September 2017 | BioPortfolio

The following people have provided quotes expressing their support to the World Hepatitis Alliance campaign for a WHO resolution on viral hepatitis. For further information please contact worldhepday@fleishman.com


News Articles [1736 Associated News Articles listed on BioPortfolio]

World Hepatitis Day sets the stage for the elimination of viral hepatitis

(World Hepatitis Alliance) Today, World Hepatitis Day, marks the first time that the global health community has come together to officially begin moving towards the elimination of viral hepatitis by ...

World Hepatitis Day – gearing towards eliminating viral hepatitis by 2030

July 28th is marked as world hepatitis day. The world is united in elimination of viral hepatitis by 2030. The World Health Organization (WHO) has published new data from 28 countries today and shown ...

Eliminate hepatitis: WHO

New WHO data from 28 countries - representing approximately 70% of the global hepatitis burden - indicate that efforts to eliminate hepatitis are gaining momentum. Published to coincide with World H...

Nine in 10 people unaware they have hepatitis

The WHO has released a report on the state of hepatitis prevention and treatment to mark World Hepatitis Day, with an emphasis that much work is left to be done to combat the viral infection. The org...

Around 9 million Europeans are affected by chronic hepatitis B or C

An estimated 4.7 million Europeans are living with chronic hepatitis B and almost 4 million (3.9) with chronic hepatitis C infection. However, large numbers of them are not even aware of their infecti...

Hepatitis C has a cure — now insurers just need to pay for it

Today is World Hepatitis Day. In The Hill newspaper, BIO CEO Jim Greenwood argues that ...

Hepatitis drugs more affordable but disease still deadly: WHO

GENEVA (Reuters) - Prices of drugs to cure hepatitis C and to treat hepatitis B are dropping dramatically, offering affordability and hope to 325 million people living with the viral liver disease tha...

ECDC estimate: Around 9 million Europeans are affected by chronic hepatitis B or C

(European Centre for Disease Prevention and Control (ECDC) ) An estimated 4.7 million Europeans are living with chronic hepatitis B and almost 4 million with chronic hepatitis C infection. But large ...

PubMed Articles [2039 Associated PubMed Articles listed on BioPortfolio]

Erratum: Vol. 66, No. 29.

In the announcement on World Hepatitis Day on page 794, the title should have read "World Hepatitis Day - July 28, 2017."

Hypothyroidism In Hepatitis C Patients On Pegylated Interferon Therapy.

Chronic hepatitis has become a major health problem all over the world especially in the third world countries. The most common cause of chronic hepatitis in Pakistan is hepatitis C which can lead Tol...

The Working Alliance in Psychiatric Care: Agreement Communication and Trust in Action.

The physician-patient working alliance has been associated with improved patient satisfaction and adherence. However, up until now there has only been a patient form with which to assess the working a...

Identification of groups with poor cost-effectiveness of peginterferon plus ribavirin for naïve hepatitis C patients with a real-world cohort and database.

For decades, peginterferon and ribavirin (PegIFN/RBV) have been the standard-of-care for chronic hepatitis C virus (CHC) infection. However, the actual cost-effectiveness of this therapy remains uncle...

Review article: hepatitis E-a concise review of virology, epidemiology, clinical presentation and therapy.

Hepatitis E virus (HEV) is a leading cause of acute icteric hepatitis and acute liver failure in the developing world. During the last decade, there has been increasing recognition of autochthonous (l...

Clinical Trials [2604 Associated Clinical Trials listed on BioPortfolio]

Construction of the Therapeutic Alliance Between Inpatient Psychiatric Patients and Nurses

Clarify the determinants of the construction of a Therapeutic Alliance (AT) between paramedical staff (nurses and caregivers ) and adult patients in a functional unit of full-time general ...

A Clinical Trial to Evaluate a Recombinant Hepatitis E Vaccine in Healthy Adults

Hepatitis E is characteristic by sporadic and local epidemic around the world, and mainly infects adults aged 15 to 40 years old, resulting in the infection rate ranged from 1% to 15%. The...

Use-Results Surveillance Study of Harvoni® in Japanese Patients With Chronic Genotype 1 Hepatitis C Virus Infection

This study will evaluate the safety and efficacy of Harvoni® (ledipasvir/sofosbuvir (LDV/SOF) fixed-dose combination (FDC)) treatment under real world use in Japan. Among adult patients w...

Effectiveness of Therapeutic Alliance and Minimal Intervention for Chronic Low Back Pain

This study aims to evaluate the effectiveness of minimal intervention and therapeutic alliance in pain, specific and general disability, global perceived effect, empathy, credibility and e...

Hepatitis C Treatment Study in Myanmar

Hepatitis C is an important health problem in Myanmar affecting around 3% of the population. New drugs have been developed which have transformed the treatment of this disease around the w...

Companies [1152 Associated Companies listed on BioPortfolio]

World Hepatitis Alliance

The following people have provided quotes expressing their support to the World Hepatitis Alliance campaign for a WHO resolution on viral hepatitis. For further information please contact worldhep...

Hepatitis B Foundation

The Hepatitis B Foundation is the only national nonprofit organization solely dedicated to finding a cure and improving the quality of life for those affected with hepatitis B worldwide through resear...

Sinovac Biotech

Sinovac Biotech Ltd. (also known in China as Beijing Kexing Bioproducts) specializes in the research, development, commercialization, and sales of human vaccines for infectious illnesses such as Hepat...

iQur Ltd

iQur® is a specialty pharmaceutical company at the forefront of international breakthroughs in the detection, treatment and monitoring of Hepatitis C and other liver diseases.iQur exists to provide c...

Alliance Solutions Group

A registered Minority Business Enterprise, Alliance Solutions Group is a full-service recruitment firm headquartered in Independence, Ohio. The company offers expertise through it...

More Information about "World Hepatitis Alliance" on BioPortfolio

We have published hundreds of World Hepatitis Alliance news stories on BioPortfolio along with dozens of World Hepatitis Alliance Clinical Trials and PubMed Articles about World Hepatitis Alliance for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of World Hepatitis Alliance Companies in our database. You can also find out about relevant World Hepatitis Alliance Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Hepatitis
Hepatitis (plural hepatitides) is a medical condition defined by the inflammation of the liver and characterized by the presence of inflammatory cells in the tissue of the organ. The condition can be self-limiting (healing on its own) or can progress to ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...


Corporate Database Quicklinks



Searches Linking to this Company Record